-
LG 101506: RXR Signaling in TNBC
2026-09-16
Explore how LG 101506, an RXR modulator, can support evidence-driven studies of nuclear receptor signaling in triple-negative breast cancer. This article separates established RBMS1–PD-L1 biology from testable RXR hypotheses and presents a practical assay framework.
-
Pcbp1, Mitochondria, and B Cell Immunity
2026-09-15
The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity, protein translation, and antibody production in B cells. Its proposed Pcbp1–Fdxr pathway links RNA control of iron–sulfur cluster biology and mitochondrial complex I activity with germinal center development and high-affinity humoral immunity.
-
Acridine Orange hydrochloride: Practical Staining Guide
2026-09-15
Acridine Orange hydrochloride is a membrane-permeable fluorescent nucleic acid dye for DNA and RNA differential staining, cell cycle analysis, apoptosis-related workflows, and flow cytofluorometric assessment. This guide covers dossier-supported handling and assay setup while identifying parameters that must be optimized locally rather than inferred from the product specification.
-
Nuclear mTORC1 Control Revealed by TerminaTOR
2026-09-14
The reference study introduces TerminaTOR, a genetically encodable inhibitor that can be directed to distinct subcellular compartments to separate lysosomal from nuclear mTORC1 functions. Its results identify nuclear mTORC1 as a regulator of CCAAT motif-containing gene transcription and provide a framework for interpreting upstream Akt perturbation without confusing it with compartment-specific mTORC1 inhibition.
-
Staurosporine Workflows for Apoptosis and Kinase Studies
2026-09-14
Build more interpretable apoptosis, kinase-signaling, and angiogenesis experiments with Staurosporine by separating broad pathway inhibition from proof of cell-death mechanism. This workflow emphasizes DMSO handling, time-resolved readouts, and orthogonal validation for reproducible cancer research.
-
Ellagic Acid: CK2 Control in Senescence Assays
2026-09-13
Ellagic acid is a selective ATP-competitive CK2 inhibitor for dissecting signaling, oxidative stress, apoptosis, and senescence-related phenotypes. This article translates machine-learning senolytic research into a rigorous assay strategy that separates CK2 target engagement from genuine senolytic selectivity.
-
ATM Inhibition, Macropinocytosis, and Tumor Metabolism
2026-09-12
The reference study shows that ATM suppression does more than disrupt DNA damage signaling: it induces macropinocytosis, enabling cancer cells to scavenge nutrients in metabolically poor environments. Its combination of cell-based assays, nutrient-rescue experiments, in vivo treatment, and tumor-fluid metabolomics identifies branched-chain amino acid dependence as a potential vulnerability of ATM-inhibited tumors.
-
QPRT, P2Y11 Signaling, and Breast Cancer Invasion
2026-09-11
The reference study identifies QPRT as a metabolic driver of breast cancer cell migration and invasion and links this phenotype to purinergic signaling and myosin light-chain phosphorylation. Its combination of expression analysis, genetic manipulation, tumor modeling, and pharmacological pathway interrogation provides a mechanistic framework for studying how NAD+ metabolism intersects with cytoskeletal control of metastasis.
-
Nigericin Sodium Salt: Practical Workflow Guide
2026-09-11
Nigericin sodium salt (SKU B7644) is a potassium ionophore for controlled studies of K+/H+ exchange, membrane ion gradients, cytoplasmic pH, and ion-dependent platelet responses. It is intended for research workflows only; it should not be used for diagnosis, patient treatment, or clinical inference from lead-ion transport observations.
-
NIH/3T3 Cells: Recovery, Culture, and QC
2026-09-10
NIH/3T3 Cells provide an adherent mouse fibroblast model for controlled culture, cell transfection studies, viral proliferation research, and oncogene research. This guide explains recovery, expansion, assay preparation, and QC while clarifying that the product dossier does not establish quantitative assay performance, viral permissiveness, or clinical applicability.
-
Vemurafenib: A Causal Probe of Melanoma Resistance
2026-09-10
Vemurafenib (PLX4032) is more than a BRAF V600E inhibitor: it is a precise pharmacological probe for connecting MAPK suppression with adaptive melanoma resistance. This guide translates multi-omics findings into genotype-aware assay design, handling decisions, and interpretable cancer biology workflows.
-
DAPI Nuclear Stain Solution: Practical Guide
2026-09-09
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane-compromised cells. It is best suited to fixed samples, dead or apoptotic cells, fluorescence microscopy, and flow cytometry, rather than routine imaging of intact live cells.
-
Nanocarrier-Mediated dsRNA Translocation Across Cuticle
2026-09-09
This study provides a mechanistic explanation for how star cationic polymer nanocarriers help double-stranded RNA cross the insect cuticle. Its evidence links nanocomplex formation, wax-layer dissolution, improved wetting, altered chitin architecture, and reduced interfacial resistance, establishing a framework for noninvasive transdermal RNAi delivery.
-
SINAT–VAB1 Control of Autophagic Degradation
2026-09-08
A 2026 Arabidopsis study identifies VAB1, a V-ATPase subunit, as a SINAT-regulated determinant of autophagic vesicle degradation. By connecting SINAT-dependent ubiquitination of VAB1 with vacuolar acidification, the work explains how defective proteolysis can compromise nutrient-starvation tolerance and accelerate leaf senescence.
-
Glucocorticoids, Kv2.1, and CaV1.2 Signaling
2026-09-08
The reference study identifies a rapid, non genomic mechanism by which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons: reduced PKA activity promotes endocytosis of Kv2.1 channel clusters, which in turn destabilizes surface CaV1.2. Its combination of calcium imaging, channel trafficking assays, reconstituted HEK293 systems, and pharmacological rescue experiments provides a useful framework for studying acute hormone control of neuronal excitability.